Enrico Picozza - May 18, 2021 Form 4 Insider Report for DermTech, Inc. (DMTK)

Role
Director
Signature
/s/ Jason S. Miller, attorney-in-fact
Stock symbol
DMTK
Transactions as of
May 18, 2021
Transactions value $
-$9,262,443
Form type
4
Date filed
5/20/2021, 08:16 PM
Next filing
May 25, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMTK Common Stock Sale -$741K -19.8K -2.46% $37.38* 786K May 18, 2021 By HLM Venture Partners IV, L.P. F1, F2
transaction DMTK Common Stock Sale -$49.5K -1.3K -0.17% $38.05* 785K May 18, 2021 By HLM Venture Partners IV, L.P. F2, F3
transaction DMTK Common Stock Sale -$3.95M -111K -14.17% $35.55* 674K May 19, 2021 By HLM Venture Partners IV, L.P. F2, F4
transaction DMTK Common Stock Sale -$1.04M -28.8K -4.28% $36.10* 645K May 19, 2021 By HLM Venture Partners IV, L.P. F2, F5
transaction DMTK Common Stock Sale -$1.23M -34.2K -5.3% $36.00* 611K May 20, 2021 By HLM Venture Partners IV, L.P. F2, F6
transaction DMTK Common Stock Sale -$1.69M -45.5K -7.45% $37.04* 565K May 20, 2021 By HLM Venture Partners IV, L.P. F2, F7
transaction DMTK Common Stock Sale -$563K -15K -2.66% $37.46* 550K May 20, 2021 By HLM Venture Partners IV, L.P. F2, F8
holding DMTK Common Stock 14K May 18, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $37.00 to $37.98, inclusive. The reported price reflects the weighted-average sale price.
F2 The reporting person has a pecuniary interest in HLM Venture Associates IV, LLC ("HLM GP"). HLM GP is the general partner of HLM Venture Partners IV, L.P., which owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F3 This transaction was executed in multiple trades at prices ranging from $38.01 to $38.13, inclusive. The reported price reflects the weighted-average sale price.
F4 This transaction was executed in multiple trades at prices ranging from $35.00 to $35.99, inclusive. The reported price reflects the weighted-average sale price.
F5 This transaction was executed in multiple trades at prices ranging from $36.00 to $36.36, inclusive. The reported price reflects the weighted-average sale price.
F6 This transaction was executed in multiple trades at prices ranging from $35.29 to $36.28, inclusive. The reported price reflects the weighted-average sale price.
F7 This transaction was executed in multiple trades at prices ranging from $36.29 to $37.28, inclusive. The reported price reflects the weighted-average sale price.
F8 This transaction was executed in multiple trades at prices ranging from $37.30 to $37.79, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (3) through (8) of this Form 4.